Primary Hormone Therapy in Elderly Women with Hormone-Sensitive Locoregional Breast Cancer: Endocrine Therapy Alone Is a Reasonable Alternative in Selected Patients | Zendy

Vanesa Quiroga-García | Zendy; Beatriz Cirauqui-Cirauqui | Zendy; Cristina Bugés-Sánchez | Zendy; Miguel A. Luna | Zendy; Eva María Castellà-Fernández | Zendy; A. Mariscal-Martínez | Zendy; Mireia Margelí Vila | Zendy

Open Access

Primary Hormone Therapy in Elderly Women with Hormone-Sensitive Locoregional Breast Cancer: Endocrine Therapy Alone Is a Reasonable Alternative in Selected Patients

Author(s) -

Vanesa Quiroga-García,

Beatriz Cirauqui-Cirauqui,

Cristina Bugés-Sánchez,

Miguel A. Luna,

Eva María Castellà-Fernández,

A. Mariscal-Martínez,

Mireia Margelí Vila

Publication year - 2015

Publication title -

breast care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.767

H-Index - 30

eISSN - 1661-3805

pISSN - 1661-3791

DOI - 10.1159/000382112

Subject(s) - medicine , hormone therapy , breast cancer , hormone receptor , aromatase , oncology , estrogen , hormone , estrogen receptor , cancer , hormone replacement therapy (female to male) , gynecology , testosterone (patch)

Treatment with aromatase inhibitors (AIs) followed by surgery is often recommended for women with locoregional hormone-sensitive breast cancer. However, no study has compared the efficacy of AIs alone versus AIs followed by surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research